Table 2.
The baseline characteristics of survivors and non-survivors infected with COVID-19
| Variable | Total (n=16,391) | Survivors (n=15,700) | Non-survivors (n=691) | p value |
|---|---|---|---|---|
| Number (%) | Number (%) | Number (%) | ||
| Age, median (IQR) | 38 (30–51) | 38 (30–50) | 66 (55–76) | <0.001 |
| Gender | ||||
| Male | 8940 (54.55) | 8424 (54.70) | 378 (54.70) | 0.986 |
| Female | 7446 (45.45) | 6966 (45.30) | 313 (45.30) | |
| Comorbidities | ||||
| Diabetes mellitus | 1365 (8.30) | 1169 (7.44) | 196 (28.40) | <0.001 |
| Hypertension | 896 (5.50) | 753 (4.79) | 143 (20.70) | <0.001 |
| Cardiovascular disease | 815 (5.00) | 673 (4.28) | 142 (20.50) | <0.001 |
| Immunodeficiency | 87 (0.50) | 72 (0.45) | 15 (2.20) | <0.001 |
| Chronic kidney disease | 285 (1.70) | 242 (1.54) | 43 (6.20) | <0.001 |
| Chronic pulmonary disease | 314 (1.90) | 283 (1.80) | 31 (4.50) | <0.001 |
| Chronic liver disease | 40 (0.20) | 38 (0.20) | 2 (0.30) | 0.797 |
| Hyperlipidemia | 52 (0.30) | 51 (0.32) | 1 (0.10) | 0.449 |